-
1 Comment
Chardan Healthcare Acquisition 2 Corp is currently in a long term downtrend where the price is trading 1.9% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
Based on the above factors, Chardan Healthcare Acquisition 2 Corp gets an overall score of 1/5.
| Exchange | NYSE MKT |
|---|---|
| CurrencyCode | USD |
| ISIN | US75989E1064 |
| Sector | Financial Services |
| Industry | Shell Companies |
| Target Price | None |
|---|---|
| Market Cap | 91M |
| PE Ratio | None |
| Beta | nan |
| Dividend Yield | None |
Chardan Healthcare Acquisition 2 Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, share exchange, stock purchase, recapitalization, reorganization, or other similar business combination. The company was incorporated in 2018 and is based in New York, New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CHAQ using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
